---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-199606"
form_type: "8-K"
ticker: "HCA"
cik: "0000860730"
company_name: "HCA Healthcare, Inc."
filed_at: "2022-07-22T23:59:59+00:00"
generated_at: "2026-06-24T09:44:39.833628+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# HCA Healthcare Q2 2022 net income down 20% to $1.155B; EPS $3.90 vs $4.36 YoY

## Summary
- Revenue $14.820B (+2.7% YoY); net income $1.155B ($3.90 EPS) vs $1.450B ($4.36) in Q2 2021.
- Adjusted EBITDA $3.042B (-5.5% YoY); same facility admissions -1.2%, equivalent admissions +0.5%.
- Operating cash flow $1.630B vs $2.251B in Q2 2021; capital expenditures $1.080B (ex-acquisitions).
- Repurchased 12.23M shares for $2.682B in Q2; $3.803B remaining under repurchase authorization.
- Board declared $0.56 quarterly dividend, payable Sept 30 to holders of record Sept 16.

## SEC filing metadata
- accession: 0001193125-22-199606
- form_type: 8-K
- ticker: HCA
- cik: 0000860730
- company_name: HCA Healthcare, Inc.
- filed_at: 2022-07-22T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/860730/000119312522199606/0001193125-22-199606-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/860730/000119312522199606/d383183d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-199606
- JSON: https://secwatch.observer/filing/0001193125-22-199606.json
- Plain text: https://secwatch.observer/filing/0001193125-22-199606.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.